Pharmaxis Ltd announced today it has issued 3.2 million shares on completion of the acquisition of Canadian based private biopharmaceutical company Topigen Pharmaceuticals Inc.The agreement to purchase Topigen was announced to the market on 12 January 2010.

Read Media Release